Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
Tenon Medical, Inc. Announces Timing of Fourth Quarter and Full Year 2023 Financial Results
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024. The Company will also hold a conference call the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
加利福尼亞州洛斯加託斯/ACCESSWIRE/2024年2月27日/Tenon Medical, Inc.（納斯達克股票代碼：TNON）（“Tenon” 或 “公司”）是一家爲某些骶骶骶關節（SI關節）患者提供護理服務的公司，今天宣佈計劃在2024年3月12日星期二收盤後發佈截至2023年12月31日的第四季度和2023年全年財務業績。該公司還將在美國東部時間當天下午 4:30 舉行電話會議，進一步詳細討論其財務業績。電話會議將以與其報道分析師的問答環節結束。
| Date: | Tuesday, March 12, 2024 |
| Time: | 4:30 p.m. Eastern time |
| Dial-in: | 1-877-407-0792 |
| International Dial-in: | 1-201-689-8263 |
| Webcast: | TNON Conference Call |
| 日期： | 2024年3月12日，星期二 |
| 時間： | 美國東部時間下午 4:30 |
| 撥入： | 1-877-407-0792 |
| 國際撥入： | 1-201-689-8263 |
| 網絡直播： | TNON 電話會議 |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
請在通話開始前至少 10 分鐘撥號，以確保及時參與。
An audio playback of the call will be available through March 26, 2024, on Tenon's Investor Relations website at or via telephone replay by dialing 1-844-512-2921(USA) or 1-412-317-6671 (International). The access code will be 13744319.
該電話會議的音頻將在2024年3月26日之前在Tenon的投資者關係網站上播放，電話號碼是撥打1-844-512-2921（美國）或1-412-317-6671（國際），也可以通過電話重播。接入碼將是 13744319。
About Tenon Medical, Inc.
關於 Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022 Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit
成立於2012年的醫療器械公司Tenon Medical, Inc. 開發了雙體船SI關節融合系統，該系統使用單一堅固的鈦植入物爲SI關節提供了一種新穎的、侵入性較小的方法。該系統採用雙體船固定裝置，該裝置穿過髂骨和骶骨的軸向和矢狀面，沿其縱軸穩定和穿過SI關節。雙體船手術方法的角度和軌跡還旨在提供一條遠離關鍵神經和血管結構並進入最強皮質骨的途徑。自2022年10月雙體船SI關節融合系統在全國上線以來，Tenon一直專注於其系統在SI關節市場的三個商業機會，其中包括：1) 初級SI關節手術，2) 失敗的SI關節植入物的修訂程序以及3) 脊柱融合結構的輔助SI關節融合術。欲了解更多信息，請訪問
The Tenon Medical logo, Tenon Medical and Catamaran are registered trademarks of Tenon Medical, Inc.
Tenon Medical 徽標、Tenon Medical 和 Catamaran 是 Tenon Medical, Inc. 的註冊商標。
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
投資者聯繫人
香農迪瓦恩
MZ 北美
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
來源：Tenon Medical, Inc.
譯文內容由第三人軟體翻譯。